In terms of the BWG: I was told that the BWG specimens were being run in both the WPI research lab and the VIP Dx clinical lab. Though the labs were kept separate, and cooperation between the two labs was already very troubled, Dr. Mikovits believed that VIP Dx would succeed, and everything would be doubly validated.
When the results of the BWG were uncoded and revealed to all nine labs (but not yet made public), in early August, WPI was left in a bad place. Dr. Mikovits says that at that time she asked WPI management to stop offering the XMRV test at VIP Dx. But the testing was not stopped. Why?
Then, when the BWG results were finally made public on September 22, Dr. Mikovits was quoted as saying, "VIPdx lab will NOT continue XMRV-testing because it hasn't been shown to be reproducible in [the] BloodWorkingGroup". Shortly after she said this, cooperation between the two labs ceased completely and the research lab was closed. Why?